ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

US Appeals Court Dismisses Fisher’s Privacy Act Suit Supporting Femara

January 10, 1997

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

Nutrition Research Tests Hypotheses, Seeks Explanation Of Differences

August 14, 1981

In Brief: Senate Tracks Reauthorization n New Institute Bill, Waxman May Go Along: Abe Goldin Dies

August 19, 1988

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982